{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T07:24:20Z","timestamp":1781940260667,"version":"3.54.5"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/rsc.li\/journals-terms-of-use"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["SFI-12\/RI\/2346\/3"],"award-info":[{"award-number":["SFI-12\/RI\/2346\/3"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"crossref","award":["SFI-12\/RI\/2346\/3"],"award-info":[{"award-number":["SFI-12\/RI\/2346\/3"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,3,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since the protein constituents of urine present a dynamic proteome that can reflect a variety of disease-related alterations in the body, the mass spectrometric survey of proteome-wide changes in urine promises new insights into pathogenic mechanisms. Urine can be investigated in a completely non-invasive way and provides valuable biomedical information on body-wide changes. In this report, we have focused on the urine proteome in X-linked muscular dystrophy using the established mdx-4cv mouse model of dystrophinopathy. In order to avoid potential artefacts due to the manipulation of the biofluid proteome prior to mass spectrometry, crude urine specimens were analyzed without the prior usage of centrifugation steps or concentration procedures. Comparative proteomics revealed 21 increased and 8 decreased proteins out of 870 identified urinary proteoforms using 50 \u03bcl of biofluid per investigated sample, i.e. 14 wild type versus 14 mdx-4cv specimens. Promising marker proteins that were almost exclusively found in mdx-4cv urine included nidogen, parvalbumin and titin. Interestingly, the mass spectrometric identification of urine-associated titin revealed a wide spread of peptides over the sequence of this giant muscle protein. The newly established urinomic signature of dystrophinopathy might be helpful for the design of non-invasive assays to improve diagnosis, prognosis, therapy-monitoring and evaluation of potential harmful side effects of novel treatments in the field of muscular dystrophy research.<\/jats:p>\n                  <jats:p\/>","DOI":"10.1039\/c9mo00182d","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T09:52:41Z","timestamp":1584525161000},"page":"268-278","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Identification of marker proteins of muscular dystrophy in the urine proteome from the\n                    <i>mdx-4cv<\/i>\n                    model of dystrophinopathy"],"prefix":"10.1093","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1005-8372","authenticated-orcid":false,"given":"Stephen","family":"Gargan","sequence":"first","affiliation":[{"name":"Kathleen Lonsdale Institute for Human Health Research, Maynooth University b , Maynooth W23F2H6, Co. Kildare, Ireland"},{"name":"Department of Biology, Maynooth University, National University of Ireland a , Maynooth W23F2H6, Co. Kildare, Ireland \u00a0 kay.ohlendieck@mu.ie \u00a0 (+353) (1) 708-3845 \u00a0 (+353) (1) 708-3842"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9290-9267","authenticated-orcid":false,"given":"Paul","family":"Dowling","sequence":"additional","affiliation":[{"name":"Kathleen Lonsdale Institute for Human Health Research, Maynooth University b , Maynooth W23F2H6, Co. Kildare, Ireland"},{"name":"Department of Biology, Maynooth University, National University of Ireland a , Maynooth W23F2H6, Co. Kildare, Ireland \u00a0 kay.ohlendieck@mu.ie \u00a0 (+353) (1) 708-3845 \u00a0 (+353) (1) 708-3842"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9471-1839","authenticated-orcid":false,"given":"Margit","family":"Zweyer","sequence":"additional","affiliation":[{"name":"Department of Neonatology and Pediatric Intensive Care, Children's Hospital, University of Bonn c , D-53113 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0923-7090","authenticated-orcid":false,"given":"Dieter","family":"Swandulla","sequence":"additional","affiliation":[{"name":"Institute of Physiology II, University of Bonn d , D-53115 Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6266-4510","authenticated-orcid":false,"given":"Kay","family":"Ohlendieck","sequence":"additional","affiliation":[{"name":"Kathleen Lonsdale Institute for Human Health Research, Maynooth University b , Maynooth W23F2H6, Co. Kildare, Ireland"},{"name":"Department of Biology, Maynooth University, National University of Ireland a , Maynooth W23F2H6, Co. Kildare, Ireland \u00a0 kay.ohlendieck@mu.ie \u00a0 (+353) (1) 708-3845 \u00a0 (+353) (1) 708-3842"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"2026010813092827900_cit1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jprot.2016.08.009","article-title":"Quantitative body fluid proteomics in medicine \u2013 A focus on minimal invasiveness","volume":"153","author":"Cs\u0151sz","year":"2017","journal-title":"J. Proteomics"},{"key":"2026010813092827900_cit2","volume-title":"Fundamentals of Urine and Body Fluid Analysis","author":"Brunzel","year":"2016"},{"key":"2026010813092827900_cit3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-94-017-9523-4_4","article-title":"Human urine proteome: a powerful source for clinical research","volume":"845","author":"Zou","year":"2015","journal-title":"Adv. Exp. Med. Biol."},{"key":"2026010813092827900_cit4","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.5213\/inj.1612720.360","article-title":"Urine Proteomics in the Era of Mass Spectrometry","volume":"20","author":"Beasley-Green","year":"2016","journal-title":"Int. Neurourol. J."},{"key":"2026010813092827900_cit5","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1038\/s41598-017-03226-6","article-title":"A comprehensive analysis and annotation of human normal urinary proteome","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."},{"key":"2026010813092827900_cit6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/prca.201500102","article-title":"Biomarker discovery in mass spectrometry-based urinary proteomics","volume":"10","author":"Thomas","year":"2016","journal-title":"Proteomics Clin Appl"},{"key":"2026010813092827900_cit7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s00120-018-0732-1","article-title":"Urinary marker-old wine in new bottles?","volume":"57","author":"Fischer","year":"2018","journal-title":"Urologe"},{"key":"2026010813092827900_cit8","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbapap.2013.06.016","article-title":"Urine as a source for clinical proteome analysis: from discovery to clinical application","volume":"1844","author":"Rodr\u00edguez-Su\u00e1rez","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"2026010813092827900_cit9","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1021\/pr2003038","article-title":"A comprehensive map of the human urinary proteome","volume":"10","author":"Marimuthu","year":"2011","journal-title":"J. Proteome Res."},{"key":"2026010813092827900_cit10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jprot.2014.07.021","article-title":"From hundreds to thousands: Widening the normal human Urinome (1)","volume":"112","author":"Santucci","year":"2015","journal-title":"J. Proteomics"},{"key":"2026010813092827900_cit11","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4137\/BMI.S26229","article-title":"Urine Proteome Biomarkers in Kidney Diseases. I. Limits, Perspectives, and First Focus on Normal Urine","volume":"11","author":"Santucci","year":"2016","journal-title":"Biomarker Insights"},{"key":"2026010813092827900_cit12","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.4155\/bio.14.210","article-title":"Advances in urinary proteome analysis and applications in systems biology","volume":"6","author":"Filip","year":"2014","journal-title":"Bioanalysis"},{"key":"2026010813092827900_cit13","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1021\/pr100835s","article-title":"Quantitative analysis of the intra- and inter-individual variability of the normal urinary proteome","volume":"10","author":"Nagaraj","year":"2011","journal-title":"J. Proteome Res."},{"key":"2026010813092827900_cit14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-4939-1872-0_12","article-title":"Quantification of proteins in urine samples using targeted mass spectrometry methods","volume":"1243","author":"Khristenko","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"2026010813092827900_cit15","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/14789450.2016.1190651","article-title":"Current state of the art for enhancing urine biomarker discovery","volume":"13","author":"Harpole","year":"2016","journal-title":"Expert Rev. Proteomics"},{"key":"2026010813092827900_cit16","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1074\/mcp.RA119.001343","article-title":"Comprehensive Analysis of Individual Variation in the Urinary Proteome Revealed Significant Gender Differences","volume":"18","author":"Shao","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"2026010813092827900_cit17","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1586\/14789450.2015.1094380","article-title":"Physiological conditions can be reflected in human urine proteome and metabolome","volume":"12","author":"Wu","year":"2015","journal-title":"Expert Rev. Proteomics"},{"key":"2026010813092827900_cit18","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"2026010813092827900_cit19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12014-016-9109-x","article-title":"Clinical utility of serum biomarkers in Duchenne muscular dystrophy","volume":"13","author":"Hathout","year":"2016","journal-title":"Clin. Proteomics"},{"key":"2026010813092827900_cit20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14789450.2018.1429923","article-title":"Proteomic serum biomarkers for neuromuscular diseases","volume":"15","author":"Murphy","year":"2018","journal-title":"Expert Rev. Proteomics"},{"key":"2026010813092827900_cit21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1080\/14737159.2019.1648214","article-title":"Emerging proteomic biomarkers of X-linked muscular dystrophy","volume":"19","author":"Dowling","year":"2019","journal-title":"Expert Rev. Mol. Diagn."},{"key":"2026010813092827900_cit22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/cjn.2015.311","article-title":"A Systematic Review and Meta-analysis on the Epidemiology of the Muscular Dystrophies","volume":"43","author":"Mah","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"2026010813092827900_cit23","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1016\/j.biocel.2013.05.001","article-title":"Wasting mechanisms in muscular dystrophy","volume":"45","author":"Shin","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"2026010813092827900_cit24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/pmic.201500158","article-title":"Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis","volume":"16","author":"Holland","year":"2016","journal-title":"Proteomics"},{"key":"2026010813092827900_cit25","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/j.2040-4603.2018.tb00051.x","article-title":"Immunobiology of Inherited Muscular Dystrophies","volume":"8","author":"Tidball","year":"2018","journal-title":"Compr. Physiol."},{"key":"2026010813092827900_cit26","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.nmd.2013.05.003","article-title":"Scoliosis in Duchenne muscular dystrophy (DMD)","volume":"23","author":"Hsu","year":"2013","journal-title":"Neuromuscular Disord."},{"key":"2026010813092827900_cit27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/dmcn.12922","article-title":"Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations","volume":"58","author":"Ricotti","year":"2016","journal-title":"Dev. Med. Child Neurol."},{"key":"2026010813092827900_cit28","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"DMD Care Considerations Working Group, Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol."},{"key":"2026010813092827900_cit29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The Pathogenesis and Therapy of Muscular Dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"2026010813092827900_cit30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.csbj.2015.11.002","article-title":"The biochemical and mass spectrometric profiling of the dystrophin complexome from skeletal muscle","volume":"14","author":"Murphy","year":"2015","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"2026010813092827900_cit31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0074-7696(07)65005-0","article-title":"Biology of the striated muscle dystrophin-glycoprotein complex","volume":"265","author":"Ervasti","year":"2008","journal-title":"Int. Rev. Cytol."},{"key":"2026010813092827900_cit32","first-page":"1","article-title":"Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers","volume":"69","author":"Ohlendieck","year":"1996","journal-title":"Eur. J. Cell Biol."},{"key":"2026010813092827900_cit33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/345315a0","article-title":"Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle","volume":"345","author":"Ervasti","year":"1990","journal-title":"Nature"},{"key":"2026010813092827900_cit34","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1212\/WNL.43.4.795","article-title":"Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma","volume":"43","author":"Ohlendieck","year":"1993","journal-title":"Neurology"},{"issue":"8","key":"2026010813092827900_cit35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2174\/13892037113146660083","article-title":"Proteomics of the dystrophin-glycoprotein complex and dystrophinopathy","volume":"14","author":"Holland","year":"2013","journal-title":"Curr. Protein Pept. Sci."},{"key":"2026010813092827900_cit36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2014.03.012","article-title":"Proteomics profiling of urine reveals specific titin fragments as biomarkers of Duchenne muscular dystrophy","volume":"24","author":"Rouillon","year":"2014","journal-title":"Neuromuscular Disord."},{"key":"2026010813092827900_cit37","doi-asserted-by":"crossref","first-page":"39375","DOI":"10.1038\/srep39375","article-title":"Establishment of a highly sensitive sandwich ELISA for the N-terminal fragment of titin in urine","volume":"6","author":"Maruyama","year":"2016","journal-title":"Sci. Rep."},{"key":"2026010813092827900_cit38","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.nmd.2017.05.009","article-title":"Dramatic elevation in urinary amino terminal titin fragment excretion quantified by immunoassay in Duchenne muscular dystrophy patients and in dystrophin deficient rodents","volume":"27","author":"Robertson","year":"2017","journal-title":"Neuromuscular Disord."},{"key":"2026010813092827900_cit39","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cca.2017.11.024","article-title":"Diagnostic and clinical significance of the titin fragment in urine of Duchenne muscular dystrophy patients","volume":"476","author":"Awano","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"2026010813092827900_cit40","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cca.2018.07.041","article-title":"Receiver operating curve analyses of urinary titin of healthy 3-y-old children may be a noninvasive screening method for Duchenne muscular dystrophy","volume":"486","author":"Matsuo","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"2026010813092827900_cit41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acc.2019.01.001","article-title":"Titin fragment in urine: A noninvasive biomarker of muscle degradation","volume":"90","author":"Matsuo","year":"2019","journal-title":"Adv. Clin. Chem."},{"key":"2026010813092827900_cit42","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/hmg\/5.8.1149","article-title":"Differential expression of dystrophin isoforms in strains of mdx mice with different mutations","volume":"5","author":"Im","year":"1996","journal-title":"Hum. Mol. Genet."},{"key":"2026010813092827900_cit43","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/mus.25566","article-title":"A new method of genotyping MDX4CV mice by PCR-RFLP analysis","volume":"56","author":"Tichy","year":"2017","journal-title":"Muscle Nerve"},{"key":"2026010813092827900_cit44","doi-asserted-by":"crossref","first-page":"14454","DOI":"10.1038\/ncomms14454","article-title":"Muscle-specific CRISPR\/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy","volume":"8","author":"Bengtsson","year":"2017","journal-title":"Nat. Commun."},{"key":"2026010813092827900_cit45","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jprot.2016.03.011","article-title":"Proteomic analysis of dystrophin deficiency and associated changes in the aged mdx-4cv heart model of dystrophinopathy-related cardiomyopathy","volume":"145","author":"Murphy","year":"2016","journal-title":"J. Proteomics"},{"key":"2026010813092827900_cit46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jprot.2018.01.015","article-title":"Proteomic analysis of the sarcolemma-enriched fraction from dystrophic mdx-4cv skeletal muscle","volume":"191","author":"Murphy","year":"2019","journal-title":"J. Proteomics"},{"key":"2026010813092827900_cit47","doi-asserted-by":"crossref","first-page":"151059","DOI":"10.1016\/j.ejcb.2019.151059","article-title":"Proteomic and cell biological profiling of the renal phenotype of the mdx-4cv mouse model of Duchenne muscular dystrophy","volume":"99","author":"Dowling","year":"2020","journal-title":"Eur. J. Cell Biol."},{"key":"2026010813092827900_cit48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/14789450.2019.1575205","article-title":"Proteomic profiling of giant skeletal muscle protein","volume":"16","author":"Murphy","year":"2019","journal-title":"Expert Rev. Proteomics"},{"key":"2026010813092827900_cit49","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3892\/ijmm.2017.2952","article-title":"Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy","volume":"39","author":"Murphy","year":"2017","journal-title":"Int. J. Mol. Med."},{"key":"2026010813092827900_cit50","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3892\/ijmm.2013.1429","article-title":"Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy","volume":"32","author":"Carberry","year":"2013","journal-title":"Int. J. Mol. Med."},{"key":"2026010813092827900_cit51","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1074\/mcp.M112.023127","article-title":"Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse","volume":"12","author":"Rayavarapu","year":"2013","journal-title":"Mol. Cell. Proteomics"},{"key":"2026010813092827900_cit52","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/pmic.201400471","article-title":"Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis","volume":"15","author":"Holland","year":"2015","journal-title":"Proteomic"},{"key":"2026010813092827900_cit53","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10974-019-09507-z","article-title":"Proteomic profiling of the mouse diaphragm and refined mass spectrometric analysis of the dystrophic phenotype","volume":"40","author":"Murphy","year":"2019","journal-title":"J. Muscle Res. Cell Motil."},{"key":"2026010813092827900_cit54","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1093\/hmg\/ddu366","article-title":"Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients","volume":"23","author":"Hathout","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"2026010813092827900_cit55","doi-asserted-by":"crossref","first-page":"43697","DOI":"10.1038\/srep43697","article-title":"Identification of serum protein biomarkers for utrophin based DMD therapy","volume":"7","author":"Guiraud","year":"2017","journal-title":"Sci. Rep."},{"key":"2026010813092827900_cit56","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1002\/pmic.201200578","article-title":"Proteomic profiling of cardiomyopathic tissue from the aged mdx model of Duchenne muscular dystrophy reveals a drastic decrease in laminin, nidogen and annexin","volume":"13","author":"Holland","year":"2013","journal-title":"Proteomics"},{"key":"2026010813092827900_cit57","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10974-017-9478-4","article-title":"Proteomic profiling of the dystrophin complex and membrane fraction from dystrophic mdx muscle reveals decreases in the cytolinker desmoglein and increases in the extracellular matrix stabilizers biglycan and fibronectin","volume":"38","author":"Murphy","year":"2017","journal-title":"J. Muscle Res. Cell Motil."},{"key":"2026010813092827900_cit58","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/prca.201300072","article-title":"Fibronectin is a serum biomarker for Duchenne muscular dystrophy","volume":"8","author":"Cynthia Martin","year":"2014","journal-title":"Proteomics Clin Appl"},{"key":"2026010813092827900_cit59","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13054-016-1314-5","article-title":"Beyond muscle destruction: a systematic review of rhabdomyolysis for clinical practice","volume":"20","author":"Chavez","year":"2016","journal-title":"Crit. Care"},{"key":"2026010813092827900_cit60","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1373\/clinchem.2009.128546","article-title":"A. El Sharif, Utility of urine myoglobin for the prediction of acute renal failure in patients with suspected rhabdomyolysis: a systematic review","volume":"55","author":"Rodr\u00edguez-Capote","year":"2009","journal-title":"Clin. Chem."},{"key":"2026010813092827900_cit61","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/mds.27782","article-title":"Antisense therapies for movement disorders","volume":"34","author":"Scoles","year":"2019","journal-title":"Mov. Disord"},{"key":"2026010813092827900_cit62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1152\/physiol.00012.2019","article-title":"CRISPR for Neuromuscular Disorders: Gene Editing and Beyond","volume":"34","author":"Young","year":"2019","journal-title":"Physiology"},{"key":"2026010813092827900_cit63","doi-asserted-by":"crossref","first-page":"113086","DOI":"10.1016\/j.expneurol.2019.113086","article-title":"Stem cell-based therapies for Duchenne muscular dystrophy","volume":"323","author":"Sun","year":"2020","journal-title":"Exp. Neurol."},{"key":"2026010813092827900_cit64","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/WCO.0000000000000739","article-title":"Update in Duchenne and Becker muscular dystrophy","volume":"32","author":"Waldrop","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"2026010813092827900_cit65","doi-asserted-by":"crossref","first-page":"e0219507","DOI":"10.1371\/journal.pone.0219507","article-title":"Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne","volume":"14","author":"Thangarajh","year":"2019","journal-title":"PLoS One"},{"key":"2026010813092827900_cit66","first-page":"100541","article-title":"Proteomic identification of elevated saliva kallikrein levels in the mdx-4cv mouse model of Duchenne muscular dystrophy","volume":"18","author":"Murphy","year":"2018","journal-title":"Biochem. Biophys. Rep."},{"key":"2026010813092827900_cit67","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ab.2008.11.024","article-title":"Quantitation of proteins using a dye-metal-based colorimetric protein assay","volume":"385","author":"Antharavally","year":"2009","journal-title":"Anal. Biochem."},{"key":"2026010813092827900_cit68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2490-12-12","article-title":"IL-8 as a urinary biomarker for the detection of bladder cancer","volume":"12","author":"Urquidi","year":"2012","journal-title":"BMC Urol."},{"key":"2026010813092827900_cit69","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/bs.mie.2016.09.013","article-title":"Filter-Aided Sample Preparation: The Versatile and Efficient Method for Proteomic Analysis","volume":"585","author":"Wi\u015bniewski","year":"2017","journal-title":"Methods Enzymol."},{"key":"2026010813092827900_cit70","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nature19949","article-title":"Mass-spectrometric exploration of proteome structure and function","volume":"537","author":"Aebersold","year":"2016","journal-title":"Nature"},{"key":"2026010813092827900_cit71","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-6740-7_4","article-title":"Label-Based and Label-Free Strategies for Protein Quantitation","volume":"1549","author":"Anand","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"2026010813092827900_cit72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-anchem-061516-045357","article-title":"Relative and Absolute Quantitation in Mass Spectrometry-Based Proteomics","volume":"11","author":"Ankney","year":"2018","journal-title":"Annu. Rev. Anal. Chem."},{"key":"2026010813092827900_cit73","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.bbapap.2013.07.017","article-title":"Comparison of label-free and label-based strategies for proteome analysis of hepatoma cell lines","volume":"1844","author":"Megger","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"2026010813092827900_cit74","doi-asserted-by":"crossref","first-page":"e0137048","DOI":"10.1371\/journal.pone.0137048","article-title":"Comparative Analysis of Label-Free and 8-Plex iTRAQ Approach for Quantitative Tissue Proteomic Analysis","volume":"10","author":"Latosinska","year":"2015","journal-title":"PLoS One"},{"issue":"D1","key":"2026010813092827900_cit75","doi-asserted-by":"crossref","first-page":"D419","DOI":"10.1093\/nar\/gky1038","article-title":"PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools","volume":"47","author":"Mi","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"2026010813092827900_cit76","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."}],"container-title":["Molecular Omics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/16\/3\/268\/65030734\/c9mo00182d.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article-pdf\/16\/3\/268\/65030734\/c9mo00182d.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:14:10Z","timestamp":1767896050000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/molecular-omics\/article\/16\/3\/268\/8286674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":76,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3,18]]}},"URL":"https:\/\/doi.org\/10.1039\/c9mo00182d","relation":{},"ISSN":["2515-4184"],"issn-type":[{"value":"2515-4184","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,1]]},"published":{"date-parts":[[2020,3,18]]},"assertion":[{"value":"This document is Similarity Check deposited","name":"similarity_check","explanation":{"URL":"https:\/\/www.crossref.org\/services\/similarity-check\/"},"group":{"name":"similarity_check","label":"SIMILARITY CHECK"}},{"value":"Supplementary Information","URL":"https:\/\/doi.org\/10.1039\/C9MO00182D","name":"related_data","group":{"name":"related_data","label":"RELATED DATA"}},{"value":"Stephen Gargan (ORCID)","URL":"http:\/\/orcid.org\/0000-0003-1005-8372","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Paul Dowling (ORCID)","URL":"http:\/\/orcid.org\/0000-0002-9290-9267","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Margit Zweyer (ORCID)","URL":"http:\/\/orcid.org\/0000-0001-9471-1839","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Dieter Swandulla (ORCID)","URL":"http:\/\/orcid.org\/0000-0003-0923-7090","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Kay Ohlendieck (ORCID)","URL":"http:\/\/orcid.org\/0000-0002-6266-4510","name":"identifier","group":{"name":"author_identifiers","label":"IDENTIFIERS"}},{"value":"Single-blind","order":2,"name":"peer_review_method","group":{"name":"peer_review_method","label":"PEER REVIEW METHOD"}},{"value":"Received 11 December 2019; Accepted 15 March 2020;  Accepted Manuscript published 18 March 2020;  Advance Article published 25 March 2020;  Version of Record published 15 June 2020","order":1,"name":"history","group":{"name":"publication_history","label":"PUBLICATION HISTORY"}}]}}